ZA200605713B - Transdermal delivery system of hormones without penetration enhancers - Google Patents

Transdermal delivery system of hormones without penetration enhancers

Info

Publication number
ZA200605713B
ZA200605713B ZA2006/05713A ZA200605713A ZA200605713B ZA 200605713 B ZA200605713 B ZA 200605713B ZA 2006/05713 A ZA2006/05713 A ZA 2006/05713A ZA 200605713 A ZA200605713 A ZA 200605713A ZA 200605713 B ZA200605713 B ZA 200605713B
Authority
ZA
South Africa
Prior art keywords
hormones
delivery system
transdermal delivery
penetration enhancers
enhancers
Prior art date
Application number
ZA2006/05713A
Other languages
English (en)
Inventor
Petra Huber
Thomas Langguth
Dirk Schenk
Michael Dittgen
Stefan Bracht
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34702342&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200605713(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA200605713B publication Critical patent/ZA200605713B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
ZA2006/05713A 2003-12-12 2006-07-11 Transdermal delivery system of hormones without penetration enhancers ZA200605713B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52871803P 2003-12-12 2003-12-12
EP03078881 2003-12-12
PCT/IB2004/052752 WO2005058287A2 (en) 2003-12-12 2004-12-10 Transdermal delivery system of hormones without penetration enhancers

Publications (1)

Publication Number Publication Date
ZA200605713B true ZA200605713B (en) 2008-01-08

Family

ID=34702342

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2006/05713A ZA200605713B (en) 2003-12-12 2006-07-11 Transdermal delivery system of hormones without penetration enhancers

Country Status (15)

Country Link
JP (1) JP4965263B2 (ja)
KR (1) KR101168449B1 (ja)
CN (1) CN1913878B (ja)
AU (1) AU2004298930B2 (ja)
BR (1) BRPI0417530B8 (ja)
CA (1) CA2549916C (ja)
CU (1) CU23868B1 (ja)
EA (1) EA011160B1 (ja)
EC (1) ECSP066694A (ja)
IL (1) IL176112A (ja)
MX (1) MXPA06006682A (ja)
NO (1) NO341989B1 (ja)
NZ (1) NZ548091A (ja)
WO (1) WO2005058287A2 (ja)
ZA (1) ZA200605713B (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME00147B (me) 2003-02-21 2010-10-10 Schering Ag Uv-stabilni transdermalni flasteri
US8962013B2 (en) 2005-05-02 2015-02-24 Bayer Intellectual Property Gmbh Multi-layered transdermal system with triazine UV absorber
DE102005050729A1 (de) * 2005-10-19 2007-04-26 Schering Ag Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption
FR2900048B1 (fr) * 2006-04-21 2012-11-16 Oreal Compositions comprenant un derive diphenyl-methane hydroxyle
ES2617334T3 (es) 2010-09-06 2017-06-16 Bayer Intellectual Property Gmbh Parches transdérmicos de dosificación baja con liberación elevada de fármaco
DE102010040299A1 (de) * 2010-09-06 2012-03-08 Bayer Schering Pharma Aktiengesellschaft Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner)
AU2015203180B2 (en) * 2010-09-06 2016-06-30 Bayer Intellectual Property Gmbh Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner)
AU2013212005A1 (en) * 2012-01-27 2014-07-31 Agile Therapeutics, Inc. Transdermal hormone delivery
US20180125860A1 (en) * 2015-05-18 2018-05-10 Agile Therapeutics, Inc. Contraceptive Compositions and Methods for Improved Efficacy and Modulation of Side Effects

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE58909570D1 (de) * 1988-10-27 1996-02-22 Schering Ag Mittel zur transdermalen applikation enthaltend gestoden
US5512292A (en) * 1990-10-29 1996-04-30 Alza Corporation Transdermal contraceptive formulations methods and devices
EP0555360A1 (en) * 1990-10-29 1993-08-18 Alza Corporation Transdermal contraceptive formulations, methods and devices
DE4329242A1 (de) * 1993-08-26 1995-03-02 Schering Ag Mittel zur transdermalen Applikation enthaltend Gestodenester
DE4405898A1 (de) * 1994-02-18 1995-08-24 Schering Ag Transdermale therapeutische Systeme enthaltend Sexualsteroide
WO1996015776A1 (fr) * 1994-11-18 1996-05-30 Hisamitsu Pharmaceutical Co., Inc. Timbre absorbable par voie percutanee
JP3534775B2 (ja) * 1995-06-07 2004-06-07 オーソ―マクニール ファーマシューティカル，インコーポレイテッド １７−デアセチルノルゲスチマートを単独でまたはエストロゲンと組み合わせて投与するための経皮パッチおよび方法
JP4346696B2 (ja) * 1996-05-28 2009-10-21 久光製薬株式会社 経皮治療用装置
JP4167750B2 (ja) * 1997-04-16 2008-10-22 久光製薬株式会社 経皮吸収用基剤及び該基剤を含有する経皮吸収製剤
JP4399044B2 (ja) * 1998-10-14 2010-01-13 久光製薬株式会社 吸収促進剤及び該吸収促進剤を有してなる経皮吸収製剤
DE19906152B4 (de) * 1999-02-10 2005-02-10 Jenapharm Gmbh & Co. Kg Wirkstoffhaltige Laminate für Transdermalsysteme
WO2001001990A1 (fr) * 1999-07-01 2001-01-11 Hisamitsu Pharmaceutical Co., Inc. Preparation adhesive pour absorption percutanee
DE10053375C1 (de) * 2000-10-27 2002-01-24 Lohmann Therapie Syst Lts Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen
US20020106402A1 (en) * 2000-12-05 2002-08-08 Hartwig Rod Lawson Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use

Also Published As

Publication number Publication date
BRPI0417530B8 (pt) 2021-05-25
CU20100143A7 (es) 2011-10-31
BRPI0417530A (pt) 2007-03-13
IL176112A0 (en) 2006-10-05
KR101168449B1 (ko) 2012-07-25
CN1913878B (zh) 2010-05-26
IL176112A (en) 2011-02-28
NZ548091A (en) 2009-12-24
WO2005058287A2 (en) 2005-06-30
CU23868B1 (es) 2013-03-27
CN1913878A (zh) 2007-02-14
KR20060128910A (ko) 2006-12-14
NO20062594L (no) 2006-07-10
ECSP066694A (es) 2006-10-31
EA011160B1 (ru) 2009-02-27
AU2004298930B2 (en) 2009-11-26
CA2549916A1 (en) 2005-06-30
EA200601089A1 (ru) 2006-12-29
JP4965263B2 (ja) 2012-07-04
AU2004298930A1 (en) 2005-06-30
MXPA06006682A (es) 2006-08-11
BRPI0417530B1 (pt) 2018-01-23
JP2007513938A (ja) 2007-05-31
WO2005058287A3 (en) 2006-03-02
NO341989B1 (no) 2018-03-12
CA2549916C (en) 2013-09-17

Similar Documents

Publication Publication Date Title
HK1132682A1 (en) Transdermal delivery system of hormones without penetration enhancers
ZA200605713B (en) Transdermal delivery system of hormones without penetration enhancers
AU2003226605A8 (en) Handheld transdermal drug delivery and analyte extraction
IL173152A0 (en) Transdermal hormone delivery system: compositions and methods
EP1802258A4 (en) BIOSYNCHRONE TRANSDERMAL MEDICINES
IL174894A0 (en) Transdermal drug delivery device
EP1680178A4 (en) SYSTEM AND METHOD FOR THE TRANSDERMAL DISTRIBUTION OF A VACCINE
EP1680057A4 (en) DEVICE AND METHOD FOR IMPROVING TRANSDERMAL DRUG DELIVERY
IL181436A0 (en) Transdermal antiemesis delivery system, method and composition therefor
EP1753380A4 (en) TRANSPARENT FORMULATIONS FOR THE DERIVATIVE DISPOSAL OF MEDICAMENTS AND METHODS OF ADMINISTRATION
AU2003221770A8 (en) Controlled release transdermal drug delivery
EP1737357A4 (en) DEVICE FOR TRANSDERING
IL178499A0 (en) Transdermal delivery system for use with basic permeation enhancers
EP1807033A4 (en) DEVICE FOR THE TRANSDERMAL ADMINISTRATION OF MEDICAMENTS, INCLUDING A PROTECTION SECURITY
ZA200711040B (en) Method and composition for transdermal drug delivery
AU2003265226A8 (en) Transdermal drug delivery device, method and use
EP1768742A4 (en) ADMINISTRATION SYSTEM FOR TRANSDERMAL IMMUNIZATION
HK1109332A1 (zh) 藻毒素的經皮給藥
AT500095B1 (de) Transdermales abgabesystem
EP1896038A4 (en) METHOD AND COMPOSITION FOR THE TRANSDERMAL DISTRIBUTION OF MEDICINAL PRODUCTS
GB0810016D0 (en) Method and system for transdermal drug delivery
IL179675A0 (en) System and method for transdermal delivery of an anticoagulant
AU2003241134A1 (en) Transdermal drug delivery system
EP1547595A4 (en) PULSE FOR TRANSDERMAL ADMINISTRATION
AU2003230034A8 (en) Transdermal delivery device for the administration of fentanyl